THE effect of increased intra-abdominal pressure due to ascites upon portal and systemic hemodynamics has not been directly documented although the hemodynamics of ascitic cirrhotic patients have been ...
Results of a randomized control trial of patients with advanced cirrhosis without recent fluoroquinolone therapy showed that norfloxacin did not reduce 6-month mortality but did appear to increase ...
PREVIOUS studies have indicated that in patients with cirrhosis the presence or absence of ascites can be explained by a consideration of hydrostatic and osmotic forces, and a similar analysis can be ...
A research team from United Kingdom described the use of radioimmunoassay to demonstrate and measure hepcidin-25 in various biological fluids. They provided evidence for the first time of the presence ...
Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission ...
This is a preview. Log in through your library . Abstract Background: Patients with severe forms of cancer are reported to have reduced concentrations of micronutrients in plasma due to the chronic ...
Pleural effusions complicate end-stage liver disease in 5% of patients. [5,6] Effusions (defined as 500 mL or more of fluid within the pleural space) are typically right-sided. [7,8] No ...
J Gastroenterol Hepatol. 2009;24(9):1494-1503. With the application of molecular approaches, efforts towards measuring the bacterial load using DNA in SBP patients have recently been made. Although ...
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell ...
A research team from United Kingdom described the use of radioimmunoassay to demonstrate and measure hepcidin-25 in various biological fluids. They provided evidence for the first time of the presence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results